Acquisition further enhances Baxter’s global renal product and therapies portfolio

0

Intravenous news: News Medical report “Baxter International Inc. today announced that the company has successfully completed the acquisition of Gambro AB, a privately held global medical technology company and leader in dialysis products based in Lund, Sweden. The transaction further enhances Baxter’s global renal leadership and provides the company with a comprehensive product and therapies portfolio to meet the needs of patients in the large and growing dialysis market.”

Main page

Share.

Leave A Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.